(Q57571575)

English

Effect of high-dose ifosfamide in advanced soft tissue sarcomas. A multicentre phase II study of the EORTC Soft Tissue and Bone Sarcoma Group

scientific article published on 01 January 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10741296%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Effect of high-dose ifosfamide in advanced soft tissue sarcomas. A multicentre phase II study of the EORTC Soft Tissue and Bone Sarcoma Group (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10741296%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

based on heuristic

inferred from title

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10741296%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10741296%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

author name string

O S Nielsen

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10741296%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

I Judson

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10741296%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Q van Hoesel

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10741296%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

A le Cesne

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10741296%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

H J Keizer

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10741296%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

A van Oosterom

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10741296%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

L Svancárová

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10741296%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

K Krzemienlecki

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10741296%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

C Hermans

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10741296%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

M van Glabbeke

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10741296%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

J W Oosterhuis

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10741296%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

J Verweij

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10741296%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

publication date

1 January 2000

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10741296%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

European Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10741296%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

36

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10741296%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10741296%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

61-67

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10741296%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

The management of adult soft tissue sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900240-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic factors in soft tissue sarcomas: the Aarhus experience

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900240-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The present state of the art in chemotherapy for soft tissue sarcomas in adults: the EORTC point of view

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900240-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of adjuvant chemotherapy in the treatment of adult soft tissue sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900240-3

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose epirubicin is not an alternative to standard-dose doxorubicin in the treatment of advanced soft tissue sarcomas. A study of the EORTC soft tissue and bone sarcoma group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900240-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Doxorubicin in relapsed soft tissue sarcoma: justification of phase II evaluation of new drugs in this disease. An EORTC Soft Tissue and Bone Sarcoma Group Study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900240-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyclophosphamide versus ifosfamide: final report of a randomized phase II trial in adult soft tissue sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900240-3

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose ifosfamide: circumvention of resistance to standard-dose ifosfamide in advanced soft tissue sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900240-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Synovial sarcoma. Uniform response of metastases to high dose ifosfamide

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900240-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Prophylaxis and reversal of ifosfamide encephalopathy with methylene-blue

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900240-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900240-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Quality control of validity of data collected in clinical trials. EORTC Study Group on Data Management (SGDM).

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900240-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The importance of dose intensity in chemotherapy of metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900240-3

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose ifosfamide in bone and soft tissue sarcomas: results of phase II and pilot studies--dose-response and schedule dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900240-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Response to ifosfamide and mesna: 124 previously treated patients with metastatic or unresectable sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900240-3

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose ifosfamide with mesna uroprotection: a phase I study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900240-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose-intensive chemotherapy with ifosfamide, epirubicin, and filgrastim for adult patients with metastatic or locally advanced soft tissue sarcoma: a phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900240-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II trial of first-line high-dose ifosfamide in advanced soft tissue sarcomas of the adult: a study of the Spanish Group for Research on Sarcomas (GEIS)

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900240-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics of ifosfamide administered according to three different schedules in metastatic soft tissue and bone sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900240-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study of continuous-infusion high-dose ifosfamide in advanced and/or metastatic pretreated soft tissue sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900240-3

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose ifosfamide plus adriamycin in the treatment of adult advanced soft tissue sarcomas: is it feasible?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900240-3

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose ifosfamide is associated with severe, reversible cardiac dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900240-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0959-8049(99)00240-3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10741296%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10741296%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57571575&oldid=1760201501"